Corrigendum: Combination therapy with fingolimod and neural stem cells promotes functional myelination in vivo through a non-immunomodulatory mechanism

• Yuan Zhang,
• Yuan Zhang,
• Xin-Yu Lu,
• Ze-Qin Ye,
• Bogoljub Ciric,
• Cun-Gen Ma,
• Abdolmohamad Rostami,
• Xing Li,
• Xing Li,
• Guang-Xian Zhang

Affiliations

Yuan Zhang

Department of Neurology, Thomas Jefferson University, Philadelphia, PA, United States

Yuan Zhang

National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, The Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, The Ministry of Education, Shaanxi Normal University, Xi'an, China

Xin-Yu Lu

National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, The Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, The Ministry of Education, Shaanxi Normal University, Xi'an, China

Ze-Qin Ye

National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, The Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, The Ministry of Education, Shaanxi Normal University, Xi'an, China

Bogoljub Ciric

Department of Neurology, Thomas Jefferson University, Philadelphia, PA, United States

Cun-Gen Ma

Department of Neurology, Institute of Brain Science, Shanxi Datong University Medical School, Datong, China

Abdolmohamad Rostami

Department of Neurology, Thomas Jefferson University, Philadelphia, PA, United States

Xing Li

Department of Neurology, Thomas Jefferson University, Philadelphia, PA, United States

Xing Li

National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, The Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, The Ministry of Education, Shaanxi Normal University, Xi'an, China

Guang-Xian Zhang

Department of Neurology, Thomas Jefferson University, Philadelphia, PA, United States